(S)-2-(6-Benzylpyridin-2-yl)-4-(tert-butyl)-4,5-dihydrooxazole, 97%, 100mg

Soluzione di modificatore della matrice di nitrato di palladio, 10 g/l Pd (NO3)2 (99,999%) in 1% HNO3

5-Chloro-2-(piperidin-4-yl)pyrimidine hydrochloride, 95+%, 250mg

1-(3-Bromo-benzenesulfonyl)-piperazine, 95.0%, 250mg

6-(Thiophen-2-yl)-1H-indazole, 95.0%, 250mg

Dimethyl 2,5-dibromoterephthalate, 95.0%, 25g

2,2-Dimethyl-2H-chromene-6-carbonitrile, 97.0%, 100mg

5-Methyl-4-phenylthiazol-2-amine hydrobromide, 97%, 5g

3-Amino-2-chloroisonicotinamide, 97.0%, 100mg

7-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline, 95.0%, 1g

7-tert-Butyl 3-ethyl 5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-3,7(8H)-dicarboxylate, 95.0%, 1g

n-Octyltrimethylammonium Chloride>98.0%(T)25g

Butyl decanoate, 98%, 5g